Plant-derived antigens as mucosal vaccines

Current Topics in Microbiology and Immunology

Volumn 354, Issue 1, 2012, Pages 101-120

  Mason, H S ^a,b   Herbst Kralovetz, M M ^a,c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Nasal immunization; Norovirus; Oral immunization; Plant viral vector; Toll like receptor agonist

Indexed keywords

ALFALFA VACCINE; APXIA PROTEIN VACCINE; APXIIA PROTEIN VACCINE; BACTERIAL VACCINE; CHOLERA TOXIN B SUBUNIT; CORN VACCINE; CPG OLIGODEOXYNUCLEOTIDE; ESCHERICHIA COLI ENTEROTOXIN; HEPATITIS B VACCINE; MEASLES VACCINE; NEWCASTLE DISEASE VACCINE; PLACEBO; PLANT DERIVED VACCINE; POTATO VACCINE; PROTEIN VP1; PROTEIN VP2; RABIES VACCINE; RICE VACCINE; TOBACCO VACCINE; TOMATO VACCINE; TRANSMISSIBLE GASTROENTERITIS VIRUS VACCINE; UNCLASSIFIED DRUG; VACCINE; VIRUS SPIKE PROTEIN; VIRUS VACCINE;

ADJUVANT THERAPY; ALFALFA; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERANCE; ESCHERICHIA COLI INFECTION; FOOT AND MOUTH DISEASE; GENE DELIVERY SYSTEM; GENE EXPRESSION SYSTEM; HUMAN; INFECTION PREVENTION; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; MUCOSAL IMMUNITY; NEWCASTLE DISEASE; NONHUMAN; NOROVIRUS; PLANT GENOME; PORCINE PLEUROPNEUMONIA; POTATO; PRIORITY JOURNAL; REVIEW; TOBACCO; TOMATO; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS ASSEMBLY; VIRUS LIKE AGENT;

ANIMALS; ANTIGENS, VIRAL; GENE EXPRESSION; HUMANS; MUCOUS MEMBRANE; PLANTS; VIRAL VACCINES; VIRUS DISEASES;

ANIMALIA; NOROVIRUS;

EID: 84856148597     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2011_158     Document Type: Review

References (73)

1. Abe N, Kodama S, Hirano T et al (2006) Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. Laryngoscope 116:407-412 (Pubitemid 44318101)
2. Arlen PA, Singleton M, Adamovicz JJ et al (2008) Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 76:3640-3650
3. Balmelli C, Roden R, Potts A et al (1998) Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 72:8220-8229 (Pubitemid 28421819)
4. Bouche FB, Steinmetz A, Yanagi Y et al (2005) Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy. Vaccine 23:2074-2077 (Pubitemid 40341429)
5. Curtiss RI, Cardineau GA (1990) Oral immunisation by transgenic plants. World Intellectual Property Organization. Washington University
6. Dus Santos MJ, Wigdorovitz A, Trono K et al (2002) A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20:1141-1147 (Pubitemid 34135950)
7. Gallichan WS, Rosenthal KL (1998) Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J Infect Dis 177:1155-1161 (Pubitemid 28194251)
8. Gelvin SB (2003) Agrobacterium-mediated plant transformation: the biology behind the "gene-jockeying" tool. Microbiol Mol Biol Rev 67:16-37 (Pubitemid 36314782)
9. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042-2048 (Pubitemid 40341424)
10. Gleba Y, Klimyuk V, Marillonnet S (2007) Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol 18:134-141 (Pubitemid 46575232)
11. Goodin MM, Zaitlin D, Naidu RA et al (2008) Nicotiana benthamiana: its history and future as a model for plant-pathogen interactions. Mol Plant Microbe Interact 21:1015-1026
12. Hammond RW, Nemchinov LG (2009) Plant production of veterinary vaccines and therapeutics. Curr Top Microbiol Immunol 332:79-102
13. Hanin M, Paszkowski J (2003) Plant genome modification by homologous recombination. Curr Opin Plant Biol 6:157-162 (Pubitemid 36463291)
14. Harandi AM, Eriksson K, Holmgren J (2003) A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 77:953-962 (Pubitemid 36055517)
15. Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11:S45-S53 (Pubitemid 40562303)
16. Howard JA (2004) Commercialization of plant-based vaccines from research and development to manufacturing. Anim Health Res Rev 5:243-245
17. Huang Z, Mason HS (2004) Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. Plant Biotechnol J 2:241-249 (Pubitemid 40199456)
18. Huang Z, Chen Q, Hjelm B et al (2009) A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng 103:706-714
19. Imaoka K, Miller CJ, Kubota M et al (1998) Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J Immunol 161:5952-5958 (Pubitemid 28535963)
20. Jiang X, Wang M, Graham DY et al (1992) Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66:6527-6532
21. Judge NA, Mason HS, O'Brien AD (2004) Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect Immun 72:168-175 (Pubitemid 38018174)
22. Kapusta J, Modelska A, Figlerowicz M et al (1999) A plant-derived edible vaccine against hepatitis B virus. Faseb J 13:1796-1799 (Pubitemid 29473341)
23. Kong Q, Richter L, Yang YF et al (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98:11539-11544 (Pubitemid 32928764)
24. Kostrzak A, Cervantes-Gonzalez M, Guetard D et al (2009) Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine 27:4798-4807
25. Kozlowski PA, Cu-Uvin S, Neutra MR et al (1997) Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65:1387-1394 (Pubitemid 27146629)
26. Kozlowski PA, Williams SB, Lynch RM et al (2002) Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 169:566-574 (Pubitemid 34686180)
27. Kunkel E, Butcher E (2002) Homeostatic chemokines and the targeting of regional immunity. Adv Exp Med Biol 512:65-72 (Pubitemid 35335191)
28. Lamphear BJ, Jilka JM, Kesl L et al (2004) A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22:2420-2424 (Pubitemid 38757339)
29. Lavelle EC (2005) Generation of improved mucosal vaccines by induction of innate immunity. Cell Mol Life Sci 62:2750-2770 (Pubitemid 41779945)
30. Lee K-Y, Kim D-H, Kang T-J et al (2006) Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol Med Microbiol 48:381-389 (Pubitemid 44736577)
31. Loza-Rubio E, Rojas E, Gomez L et al (2008) Development of an edible rabies vaccine in maize using the Vnukovo strain. Dev Biol (Basel) 131:477-482
32. Marillonnet S, Giritch A, Gils M et al (2004) In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc Natl Acad Sci USA 101:6852-6857 (Pubitemid 38596407)
33. Mason HS, Lam DM-K, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89:11745-11749 (Pubitemid 23004720)
34. Mason HS, Ball JM, Shi J-J et al (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93:5335-5340 (Pubitemid 26159450)
35. Mason HS, Haq TA, Clements JD et al (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343 (Pubitemid 28312443)
36. McAleer WJ, Buynak EB, Maigetter RZ et al (1984) Human hepatitis B vaccine from recombinant yeast. Nature 307:178-180 (Pubitemid 14132908)
37. McCluskie MJ, Weeratna RD, Davis HL (2000) Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol Med 6:867-887
38. Monger W, Alamillo JM, Sola I et al (2006) An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts. Plant Biotechnol J 4:623-631 (Pubitemid 44581504)
39. Muller CP, Marquet-Blouin E, Fack F et al (2003) Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults. Vaccine 21:816-819 (Pubitemid 36092005)
40. Nagarajan T, Rupprecht CE, Dessain SK et al (2008) Human monoclonal antibody and vaccine approaches to prevent human rabies. Curr Top Microbiol Immunol 317:67-101
41. Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148-158 (Pubitemid 43361590)
42. Nochi T, Takagi H, Yuki Y et al (2007) Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination. Proc Natl Acad Sci USA 104:10986-10991 (Pubitemid 47175213)
43. Richter LJ, Thanavala Y, Arntzen CJ et al (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18:1167-1171
44. Rudin A, Riise GC, Holmgren J (1999) Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun 67:2884-2890 (Pubitemid 29244704)
45. Rybicki EP (2009) Plant-produced vaccines: promise and reality. Drug Discov Today 14:16-24
46. Sakaguchi S, Yamaguchi T, Nomura T et al (2008) Regulatory T cells and immune tolerance. Cell 133:775-787 (Pubitemid 351707693)
47. Santi L, Huang Z, Mason H (2006) Virus-like particles production in green plants. Methods 40:66-76 (Pubitemid 44415500)
48. Santi L, Batchelor L, Huang Z et al (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26:1846-1854
49. Shin SJ, Bae JL, Cho YW et al (2005) Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol Med Microbiol 43:155-164 (Pubitemid 40170284)
50. Shin SJ, Shin SW, Kang ML et al (2007) Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuro-pneumoniae ApxIA or ApxIIA in mice. J Vet Sci 8:383-392
51. Singh ND, Ding Y, Daniell H (2009) Chloroplast-derived vaccine antigens and biopharmaceu-ticals: protocols for expression, purification, or oral delivery and functional evaluation. Methods Mol Biol 483:163-192
52. Staats HF, Montgomery SP, Palker TJ (1997) Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses 13:945-952 (Pubitemid 27334700)
53. Streatfield SJ (2005) Oral hepatitis B vaccine candidates produced and delivered in plant material. Immunol Cell Biol 83:257-262 (Pubitemid 40799553)
54. Streatfield SJ (2006) Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150-157 (Pubitemid 43163476)
55. Streatfield SJ, Lane JR, Brooks CA et al (2003) Corn as a production system for human and animal vaccines. Vaccine 21:812-815 (Pubitemid 36092004)
56. Tacket CO, Mason HS, Losonsky G et al (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4:607-609 (Pubitemid 28237361)
57. Tacket CO, Mason HS, Losonsky G et al (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305 (Pubitemid 30497819)
58. Tacket CO, Sztein MB, Losonsky GA et al (2003) Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 108:241-247 (Pubitemid 37117370)
59. Tacket CO, Pasetti MF, Edelman R et al (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22:4385-4389 (Pubitemid 39334819)
60. Thanavala Y, Mahoney M, Pal S et al (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA 102:3378-3382 (Pubitemid 40328053)
61. Thanavala Y, Huang Z, Mason HS (2006) Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccines 5:249-260 (Pubitemid 44179954)
62. Velasquez LS, Hjelm BE, Arntzen CJ, Herbst-Kralovetz MM (2010) An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol 17(12):1850-1858
63. Webster DE, Thomas MC, Huang Z, Wesselingh SL (2005) The development of a plant-based vaccine for measles. Vaccine 23:1859-1865 (Pubitemid 40331859)
64. Webster DE, Smith SD, Pickering RJ et al (2006) Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination. Vaccine 24:3538-3544
65. Wigdorovitz A, Carrillo C, Dus Santos MJ et al (1999) Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255:347-353 (Pubitemid 29393346)
66. Wu H, Singh NK, Locy RD et al (2004a) Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana. Biotechnol Lett 26:787-792 (Pubitemid 38982855)
67. Wu H, Singh NK, Locy RD et al (2004b) Immunization of chickens with VP2 protein of infectious bursal disease virus expressed in Arabidopsis thaliana. Avian Dis 48:663-668 (Pubitemid 40234394)
68. Wu J, Yu L, Li L et al (2007) Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 5:570-578 (Pubitemid 47196367)
69. Yang CD, Liao JT, Lai CY et al (2007) Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol 7:62
70. Yusibov V, Rabindran S (2008) Recent progress in the development of plant derived vaccines. Expert Rev Vaccines 7:1173-1183
71. Yusibov V, Hooper DC, Spitsin SV et al (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20:3155-3164
72. Yusibov V, Rabindran S, Commandeur U et al (2006) The Potential of Plant Virus Vectors for Vaccine Production. Drugs R D 7:203
73. Zhang X, Buehner NA, Hutson AM et al (2006) Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 4:419-432 (Pubitemid 43886814)